Trials / Completed
CompletedNCT04780763
Effect of 4-week Oral Administration of a Fermented Dairy Product Containing Lactobacillus Rhamnosus CNCM I-3690, on Subjective State Anxiety Levels in Healthy Women Undergoing Academic Stress.
Effect of 4-week Oral Administration of a Fermented Dairy Product Containing Lactobacillus Rhamnosus CNCM I-3690, on Subjective State Anxiety Levels in Healthy Women Undergoing Academic Stress. A Proof-of-efficacy, Randomized, Controlled, Double-blind, Monocentric, Parallel Arms Design Study.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 168 (actual)
- Sponsor
- Danone Global Research & Innovation Center · Industry
- Sex
- Female
- Age
- 20 Years – 30 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the effect of Lactobacillus rhamnosus CNCM I-3690 consumption on subjective anxiety levels in healthy subjects undergoing academic stress.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Milk product fermented by lactic bacteria or not fermented | 2 bottles of 100g consumed daily during 28 days |
Timeline
- Start date
- 2021-03-04
- Primary completion
- 2021-09-14
- Completion
- 2021-12-22
- First posted
- 2021-03-03
- Last updated
- 2022-03-23
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT04780763. Inclusion in this directory is not an endorsement.